ClinicalTrials.gov
public full text
Public Domain
Endpoint Determination Study Protocol
This study is designed to evaluate the most applicable endpoints for evaluation of the Biomerica InFoods® IBS product.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effect of Dietary Supplementation on Intestinal Barrier Function in IBS-D#871717
- Setting expectations for current and future directions of native mass spectrometry in the biopharmaceutical industry#642664
- Precision Genomics Medicine Biobank#1074460
- Le French Gut: Characterization of Gut Microbiota Profiles in France#812082
- Advancing IBD Management: A Literature Review on the Role of Non-Invasive Blood-Based Biomarkers in Predicting and Assessing Pharmacodynamic Response to Treatment.#143159
Record · ID 1087338
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive